Hangzhou AGS Medtech(688581.SH) granted 391,500 restricted shares at a price of 70 yuan per share.
Hangzhou AGS Medtech(688581.SH) announcement, the restrictive stock grant conditions stipulated in the company's 2023 restricted stock incentive plan have been achieved. The company has determined September 7, 2023 as the initial grant date for the restricted stocks of this equity incentive plan. It will grant 391,500 restricted stocks at a price of 70 yuan per share to 69 eligible incentive recipients.
Related Articles
Experiencing fear of falling overwhelms the need for safety. Hedging and selling stock options plummet, reducing insurance costs. Analysts: the market has not yet fully transitioned to being bullish.
Excess supply pressure in the U.S. natural gas market intensifies, hedge funds collectively bet on price decline for the first time in two years.
SpaceX wins over $4 billion contract from the US Department of Defense to build a satellite tracking system for Trump's "Space Fence" defense program.
Experiencing fear of falling overwhelms the need for safety. Hedging and selling stock options plummet, reducing insurance costs. Analysts: the market has not yet fully transitioned to being bullish.
Excess supply pressure in the U.S. natural gas market intensifies, hedge funds collectively bet on price decline for the first time in two years.
SpaceX wins over $4 billion contract from the US Department of Defense to build a satellite tracking system for Trump's "Space Fence" defense program.
